Is there an expanded role for digoxin in patients with heart failure and sinus rhythm? An antagonist viewpoint

Annals of Pharmacotherapy

Volumn 31, Issue 7-8, 1997, Pages 893-896

  Munger, Mark A ^a,b   Furniss, Shawn M ^b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADRENERGIC SYSTEM; DRUG BLOOD LEVEL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; INOTROPISM; MORTALITY; NEUROMODULATION; NOTE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINUS RHYTHM; SUDDEN DEATH; SURVIVAL; SYMPATHETIC TONE;

EID: 0030861204     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100717     Document Type: Note

References (36)

1. Beamish RE. Heart failure: the ironic failure of success (letter). Can J Cardiol 1994;10:603.
2. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
3. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-35.
4. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20: 248-54.
5. Weber KT, Andrews V, Janicki JS, Likoff M, Reichek N. Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure. Circulation 1982;66:1262-7.
6. Packer M, Francis GS, Abrams J, Cobb FR, Eichhorn EJ, Giles JD, et al. Oral milrinone increases the risk of sudden death in severe chronic heart failure: the PROMISE trial (abstract). Circulation 1991;84(suppl II):II-310.
7. ACC/AHA Task Force Report. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol 1995;26:1376-98.
8. Mason DT, Braunwald E. Studies of digitalis: X. Effects of ouabain on forearm vascular resistance and venous tone in normal subjects and patients with heart failure. J Clin Invest 1964;43:532-43.
9. van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PHJM, Boomsma F, Lie KI, for the DIMT Study Group. Double-blind, placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT) J Am Coll Cardiol 1993;22:1564-73.
10. Ribner HS, Plucinski DA, Hsieh AM, Bresnahan D, Molteni A, Askenazi J, et al. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic-hormonal study. Am J Cardiol 1985;56:896-904.
11. Covit AB, Schaer GL, Sealy JE, Laragh JH, Cody RJ. Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure. Am J Med 1983;75:445-7.
12. Ferrari A, Gregorini L, Ferrari MC, Preti L, Mancia G. Digitalis and baroreceptor reflexes in man. Circulation 1981;63:279-85.
13. Ferguson DW, Abboud FM, Mark AL. Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation 1984;69:451-60.
14. Brouwer J, van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PHJM, Haaksma J, Lie KI. Circadian pattern of heart rate variability in heart failure is progressively disturbed with increasing neurohormonal activation (abstract). J Am Coll Cardiol 1994;23(suppl A):392A.
15. Jaeschke R, Oxman AD, Guyatt GH. To what extent do congestive heart failure patients in normal sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis. Am J Med 1990;88:279-86.
16. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK, on behalf of the PROVED Investigative Group. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure. J Am Coll Cardiol 1993;22:955-62.
17. Packer M, Gheorghiade M, Young JB, Constantini PJ, Adams KF, Cody RJ, for the RADIANCE Study. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med 1993;329:1-7.
18. de Bono D. Digoxin in eurhythmic heart failure: PROVED or "not proven"? Lancet 1994;343:128-9.
19. Just H, Drexler H, Taylor SH, Siegrist J, Schulgen G, Schumacher M, for the CADS Study Group. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. Herz 1993;18(suppl 1):436-43.
20. Kleber FX, Thyroff-Friesinger U. Ibopamine versus digoxin in the treatment of mild congestive heart failure. Cardiology 1990;77(suppl 5):75-80.
21. Yusef S, Garg R, Smith R, Dagenais G, Montague T, Arnold M, et al. Which heart failure patients benefit the most from long term digoxin therapy (abstract)? Circulation 1996;94(suppl I):I-23.
22. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R, for Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994;344:493-8.
23. Singh SN, Fletcher RD, Fisher SG, Lewis HD, Deedwania PC, Massie BM, et al., and the CHF STAT Investigators. Results of the Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (Veterans Affairs Cooperative Study Program #320) (abstract). Circulation 1994;90:I-546.
24. Packer M, O'Conner CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, et al., for the Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996;335:1107-14.
25. Køber L, Torp-Pedersen C, Gadsbøll N, Hildebrandt P, Høilund-Carlsen PF. Is digoxin an independent risk factor for long-term mortality after acute myocardial infarction? Eur Heart J 1994;15:382-8.
26. Luu M, Stevenson WG, Stevenson LW, Baron K, Waiden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989;80:1675-80.
27. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
28. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, et al., for the Captopril-Digoxin Study Group. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 1989; 14:564-70.
29. Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation 1992;85(suppl I):I50-6.
30. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al., for the U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
31. Stevenson WG, Wiener I, Yeatman L, Wohlgelertner D, Weiss JN. Complicated atherosclerotic lesions: a potential cause of ischemic ventricular arrhythmias in cardiac arrest survivors who do not have inducible ventricular tachycardia. Am Heart J 1988;116:1-6.
32. Mancini DM, Benotti JR, Elkayam U, Francis GS, Hess ML, Massie BM, et al., and the PROMISE Investigators and Coordinators. Antiarrhythmic drug use and high serum levels of digoxin are independent adverse prognostic factors in patients with chronic heart failure (abstract). Circulation 1991;84(suppl II):II-243.
33. Krum H, Bigger JT, Goldsmith RL, Packer M. Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol 1995;25:289-94.
34. Gheorghiade M, Hall VB, Jacobson G, Alam M, Rosman H, Goldstein S. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors. Circulation 1995;92:1801-7.
35. Fergusen JJ. Meeting highlights of the American College of Cardiology 45th Annual Scientific Sessions, Orlando, FL, March 24-27, 1996. Circulation 1996;94:3.
36. The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988;259:539-44.